Therefore, the European Reference Network for rare Genetic Tumour Risk Syndromes (ERN GENTURIS) recommends using the name heritable TP53-related cancer syndrome (hTP53rc) rather than LFS [3]. This evidence concerns the gene TP53 and neoplastic syndrome.